In India, National Tuberculosis Program (NTP) begun in 1962 for domiciliary treatment with standard drug regimens. “Revised National Tuberculosis Control Program (RNTCP)” was started in 1997 with the adoption of “Directly Observed Treatment Short Course Chemotherapy (DOTS)” and scaling up of “Cartridge Based Nucleic Acid Amplification Test (CBNAAT)” testing facilities [4]. National Tuberculosis Elimination Program (NTEP) was launched in 2020 with the adoption of Drug Sensitivity Testing (DST). NTEP accelerated its pace towards ending TB by 2025 by using the National Strategic Plan (NSP) (2017-25). Four pillars of the plan are, Detect, Treat, Prevent and Build to prevent the emergence of TB [4]. The above steps have been successful in bringing down the TB incidence from 201cases/lakh population in 2015 to 172 cases/lakh population in 2022 and mortality from 20 death/lakh population in 2015 to 16 deaths per lakh population in 2022 [5].
Elimination is the intentional process of bringing the incidence of a certain illness in a designated geographic region down to zero [6]. In the year 2020, NTEP had set the target of elimination of TB by 2025. In spite of the aforementioned steps to end TB, the incidence of tuberculosis India stood at 172 cases/lakh population in the year 2022 [5]. In order to achieve the target of zero incidence at national level, collective and accelerated steps are to be taken to address the epidemiological triad in tuberculosis. Tuberculosis results from complex interplay between various factors such as drug resistance of the bacterium, environmental factors such as physical and social living conditions, health and immune status of the host, health care seeking behavior of patients, availability of services, adherence to treatment and care giver support. There is a need to examine these social factors and health system related factors in a comprehensive manner, which in turn will assist in India’s journey towards achieving the TB elimination. Qualitative research plays a key role in understanding these social and health system factors, which are context specific. When multiple qualitative studies are available, it becomes vital to use a systematic approach to identify, appraise, and synthesize their findings for a meaningful understanding. Qualitative evidence synthesis (QES) or meta-synthesis enables us to achieve this.
Qualitative Meta-Analysis (QMA) is defined as “the aggregating of group of studies for the purposes of discovering the essential elements and translating the results into an end product that transforms the original results into a new conceptualization” [21]. As per Sandelowski, Meta synthesis is an “Integration that are more than the sum of parts as they offer opportunity for novel interpretations of findings” [8]. Qualitative Meta synthesis or QES is popular form of QMA [22]. The aim of meta-synthesis is to integrate qualitative research and synthesize qualitative studies on a topic of interest in order to locate key themes that provide more powerful explanations for the phenomena under review [9].The meta-analytic approach to findings of individual qualitative studies may be referred to in the literature by other terms such as qualitative meta-synthesis, meta-study, meta-ethnography. We would be using qualitative meta-synthesis approach in our study as it is best suited method of qualitative evidence synthesis in healthcare research.
So far, only two qualitative meta-synthesis regarding tuberculosis were conducted in India. The study by Shringarpure et al, [7]. is a qualitative meta-synthesis that primarily focusses on patients’ adherence to anti tuberculosis drugs, one of the components under the tuberculosis treatment. The aspects prior to treatment initiation such as screening for tuberculosis, and confirmation of diagnosis were not reviewed in the above study. It includes the primary articles published till 2020, which is before the launch of NTEP. It includes findings from the countries of India, Nepal, Pakistan, and Bangladesh, hence, they may not be very specific to India. The study by Rakesh et al was exclusively on private sector engagement in TB care in India and has not included the findings from public sector for TB care.
Thus, there is a dearth in literature for developing better context specific interventions, in depth analysis of all facilitators and barriers to tuberculosis diagnosis and treatment in India is required. In the proposed meta-synthesis, we will review the enablers, and challenges at various levels in a patient’s pathway to TB cure right from screening, detection, confirmation of diagnosis, treatment, and its adherence. We will be including studies till January 2025 which includes the period after the launch of NTEP, and findings from both public as well as private health sectors. This is particularly important when India is aspiring towards TB elimination.
Purpose Statement
To collate and synthesize various facilitators and barriers to tuberculosis diagnosis and treatment in India. Framework and detailed eligibility criteria of the review question is enumerated in Table S2